Guardant Health, Inc.
Status: Publicly traded
Direct answer
Guardant Health, Inc. is publicly traded on NASDAQ under the ticker GH.
Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and...
Can you invest in Guardant Health, Inc.?
Yes. Guardant Health, Inc. trades publicly on NASDAQ as GH.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Guardant Health, Inc.
Detailed equity research is provided by MarketSnap.